Global Human Microchipping Market Size, Share, and COVID-19 Impact Analysis, By Technology (RFID, NFC, and Others), By Type (Non-Implantable Microchips, Implantable Microchips), By Application (Personal Identification and Access Control, Medical Identification and Monitoring, Financial Transactions, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Healthcare

RELEASE DATE Apr 2024
REPORT ID SI4234
PAGES 200
REPORT FORMAT PathSoft

Global Human Microchipping Market Insights Forecasts to 2033

  • The Global Human Microchipping Market Size was Valued at USD 1.42 Billion in 2023
  • The Market Size is Growing at a CAGR of 6.07% from 2023 to 2033
  • The Worldwide Human Microchipping Market Size is Expected to Reach USD 2.56 Billion by 2033
  • Asia Pacific is Expected to Grow the fastest during the forecast period.

Global Human Microchipping Market

Get more details on this report -

Request Free Sample PDF

The Global Human Microchipping Market Size is Anticipated to Exceed USD 2.56 Billion by 2033, Growing at a CAGR of 6.07% from 2023 to 2033.

 

Market Overview

Human microchipping is a procedure that involves the implantation of small integrated circuits, usually beneath the skin, to fulfill a variety of functions. The use of human microchipping provides benefits such as easy access to health information during emergencies, automated device maintenance, and increased convenience in daily activities. Furthermore, human microchipping is the implantation of miniature RFID (Radio-Frequency Identification) or NFC (Near-Field Communication) chips beneath the skin. These chips, which are typically as little as a grain of rice, can contain personal information, and medical data, and even function as access keys to various facilities. The goal of human microchipping is to create a convenient and secure way for individuals to engage with technology, access services, and retain important information. The global human microchipping market is expected to increase over the forecast period due to several benefits, including improving security and combating fraud and theft. Furthermore, growing awareness of the potential benefits and capabilities of human microchipping is one of the main drivers driving the global market for this technology. As individuals become more knowledgeable about the technology and its uses, the concept of implanting microchips beneath the skin becomes more and more acceptable.

 

Report Coverage

This research report categorizes the market for the global human microchipping market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global human microchipping market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global human microchipping market.

 

Global Human Microchipping Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023 :USD 1.42 Billion
Forecast Period:2023-2033
Forecast Period CAGR 2023-2033 :6.07%
2033 Value Projection:USD 2.56 Billion
Historical Data for:2019-2022
No. of Pages:200
Tables, Charts & Figures:110
Segments covered:By Technology, By Type, By Application, By Region
Companies covered::Biohax International AB, VeriChip Corporation, Three Square Market, Dangerous Things LLC, McAfee Corp., Kaspersky Lab, ARM Holdings plc, Symantec Corporation, Texas Instruments Inc., NXP Semiconductors N.V., and Others Key Vendors
Pitfalls & Challenges:Covid-19 Empact, Challenges, Growth, Analysis.

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The healthcare industry is a key driver of the human microchipping market. Microchips are used in the healthcare industry for a wide range of applications, including patient identification, access control, and management of medications. Microchips can be used to recognize patients in healthcare facilities and other healthcare settings, helping to improve patient safety and security. Microchips might additionally be utilized to control access to limited areas in hospitals and other medical centers, thereby reducing unauthorized access. Microchips can also be used for handling patients' medications, improving compliance, and reducing medication errors. Furthermore, the human microchipping market's acceptance and growth are heavily reliant on government and industry support and regulations. Concerns regarding personal privacy have slowed the adoption of human microchipping. Regulatory bodies have initiated steps to ensure that user's data is secure and private. Guidelines for data encryption and permission from users are under development to protect user data. Ethical concerns about the potential misuse of microchips prompted regulatory bodies to establish ethical standards. These standards govern the proper use of microchips and help to prevent coercive or exploitative behavior.

 

Restraining Factors

However, a significant issue that is anticipated to impede the growth of the global human microchipping market over the forecast period is the possibility of cyberattacks to pose as individuals or eavesdrop on their activities.

 

Market Segmentation

The global human microchipping market share is classified into technology, type, and application.

  • The RFID segment is expected to hold the largest share of the global human microchipping market during the forecast period.   

Based on the technology, the global human microchipping market is divided into RFID, NFC, and others. Among these, the RFID segment is expected to hold the largest share of the global human microchipping market during the forecast period. RFID (Radio Frequency Identification) technology has become more and more popular in the human microchipping sector. RFID uses electromagnetic fields to identify and track objects. These chips can wirelessly transfer data to RFID readers and scanners and have a unique identification number on them. Higher security for access control and personal identification is provided by RFID chips. Due to these factors, the RFID segment is anticipated to dominate the global human microchipping market.

 

  • The implantable microchips segment is expected to grow at the fastest CAGR in the global human microchipping market during the forecast period.   

Based on the type, the global human microchipping market is divided into non-implantable microchips and implantable microchips. Among these, the implantable microchips segment is expected to grow at the fastest CAGR in the global human microchipping market during the forecast period. Implantable microchips are tiny electronic devices that can be placed beneath the skin, usually in the hand, wrist, or arm. They are often referred to as RFID (Radio-Frequency Identification) implants or biochips. They are becoming more and more well-known for their capacity to increase security, expedite procedures, and raise consumer's standard of living. The expanding use of implantable microchips in healthcare is one of the main factors driving this trend. Continuous monitoring of a patient's vital signs, chronic diseases, and medication adherence are made possible by implantable microchips. Remote access to real-time data allows medical professionals to provide more efficient and individualized care.

 

  • The medical identification and monitoring segment is expected to grow at the fastest CAGR in the global human microchipping market during the forecast period.   

Based on the application, the global human microchipping market is divided into personal identification and access control, medical identification and monitoring, financial transactions, and others. Among these, the medical identification and monitoring segment is expected to grow at the fastest CAGR in the global human microchipping market during the forecast period. The growing usage of microchips in the healthcare sector for medicine administration, access control, and patient identification. Due to this, the medical identification and monitoring segment is growing rapidly in the global human microchipping market.

 

Regional Segment Analysis of the Global Human Microchipping Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

 

North America is anticipated to hold the largest share of the global human microchipping market over the predicted timeframe.

North America

Get more details on this report -

Request Free Sample PDF

North America is anticipated to hold the largest share of the global human microchipping market over the predicted timeframe. Technological innovation has always been at the forefront in North America, especially in the United States. Prominent technology companies and startups from Silicon Valley and other tech hotspots throughout the continent have made significant investments in the study and advancement of microchipping technology. Because of its innovative leadership, North America has been able to influence the direction of the human microchipping market, creating new uses and spurring expansion. The strong ecosystem of research and development in North America is one of the main reasons for the region's leadership in the human microchipping market.

 

Asia Pacific is expected to grow at the fastest pace in the global human microchipping market during the forecast period. Human microchipping is becoming more and more popular in the Asia Pacific area, especially in nations like China, Japan, and South Korea. These nations have led the way in technological innovation and have witnessed the use of microchips in industries like payments and healthcare.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global human microchipping market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Biohax International AB
  • VeriChip Corporation
  • Three Square Market
  • Dangerous Things LLC
  • McAfee Corp.
  • Kaspersky Lab
  • ARM Holdings plc
  • Symantec Corporation
  • Texas Instruments Inc.
  • NXP Semiconductors N.V.
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global human microchipping market based on the below-mentioned segments: 

 

Global Human Microchipping Market, By Technology

  • RFID
  • NFC
  • Others

 

Global Human Microchipping Market, By Type

  • Non-Implantable Microchips
  • Implantable Microchips

 

Global Human Microchipping Market, By Application

  • Personal Identification and Access Control
  • Medical Identification and Monitoring
  • Financial Transactions
  • Others

 

Global Human Microchipping Market, Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions (FAQ)

  • 1. Which are the key companies that are currently operating within the market?
    Biohax International AB, VeriChip Corporation, Three Square Market, Dangerous Things LLC, McAfee Corp., Kaspersky Lab, ARM Holdings plc, Symantec Corporation, Texas Instruments Inc., NXP Semiconductors N.V., and Others.
  • 2. What is the size of the global human microchipping market?
    The Global Human Microchipping Market is expected to grow from USD 1.42 Billion in 2023 to USD 2.56 Billion by 2033, at a CAGR of 6.07% during the forecast period 2023-2033.
  • 3. Which region is holding the largest share of the market?
    North America is anticipated to hold the largest share of the global human microchipping market over the predicted timeframe.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies